San Francisco, CA — BookEase, the fast-growing booking platform known for simplifying service reservations across dining, wellness, and local businesses, today announced a $12 million Series A funding round. The investment, led by Summit Partners with participation from existing backer Y Combinator and angel investors in the health-tech space, will fuel the company’s strategic expansion into healthcare appointment scheduling.
Founded in 2022, BookEase has quickly captured market share by offering a frictionless, mobile-first booking experience. With over 50,000 active users and partnerships spanning 2,000+ service providers, the platform is now turning its attention to one of the most fragmented and inefficient sectors in the economy: healthcare scheduling.
Why Healthcare? Why Now?
The patient scheduling landscape remains heavily reliant on legacy systems, phone queues, and manual coordination. Industry reports consistently highlight that administrative burden and no-show rates cost US healthcare providers an estimated $150 billion annually. BookEase’s leadership sees a clear opportunity to apply its proven matching engine, automated reminders, and real-time availability infrastructure to clinical workflows.
"Healthcare deserves the same booking experience consumers expect when reserving a table or booking a fitness class. We’re not just building another calendar tool—we’re designing a patient-first scheduling layer that reduces administrative friction and puts more time back into care." — Maya Lin, Co-Founder & CEO of BookEase
🔑 Key Highlights of the Raise
- $12M Series A led by Summit Partners
- Primary use of funds: Healthcare vertical development (40%), EHR integration partnerships (30%), engineering & AI matching (20%), market expansion (10%)
- Timeline: Beta launch Q1 2026, pilot with 50+ clinics Q2 2026, full commercial rollout Q4 2026
- Compliance: Building HIPAA-compliant infrastructure from day one
Tech-First Approach to Clinical Scheduling
Unlike traditional practice management software, BookEase’s healthcare module will operate as an interoperable scheduling layer that sits alongside existing EHR systems. The platform will leverage AI-driven slot optimization, patient preference learning, and automated rescheduling to minimize gaps and reduce cancellations.
Early technical milestones include FHIR-compliant data exchange, two-way sync with Epic and Athenahealth, and a provider dashboard that tracks utilization rates, no-show trends, and patient satisfaction metrics. BookEase’s CTO emphasized that security and compliance are foundational, not afterthoughts.
"We’re architecting this with zero-trust security, end-to-end encryption, and strict role-based access controls. Our goal is to become the scheduling partner that clinics trust with both efficiency and compliance." — David Park, Co-Founder & CTO
What’s Next for BookEase
Following the close of the Series A, BookEase will onboard a dedicated healthcare product team and begin recruitment for clinical operations advisors. The company has already initiated pilot discussions with multi-specialty clinics in California and Texas, focusing on primary care, dermatology, and physical therapy workflows.
The expansion also signals a broader product philosophy: vertical specialization without fragmentation. BookEase will continue supporting its existing service categories while offering healthcare providers a tailored, compliant, and scalable scheduling experience.
For providers interested in early access to the healthcare beta, or investors seeking to learn more about the round, visit bookease.com/healthcare or contact the investor relations team at ir@bookease.com.